The First Crispr Medicine Is Now Approved in the US
The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell transplant.
Related articles
-
McGregor fined, avoids jail for hitting man at bar
November 1, 2019 -
'Equality' most dominant message for NBA jerseys
July 8, 2020
